ArticleFrontiers in oncology2025
A compact C-band FLASH electron linear accelerator prototype for the VHEE SAFEST project.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
FLASH therapy, a novel cancer treatment technique, aims to control tumor growth, sparing the healthy tissue from radiation damage and thus increasing the therapeutic ratio. Translating FLASH therapy into clinical practice, especially for treating deep-seated tumors, necessitates achieving Very High-Energy Electron (VHEE) levels within the 50-250 MeV range. In 2022 Sapienza University, in collaboration with INFN, launched the SAFEST project, a compact C-band 100 MeV Ultra-High Dose Rate (UHRD) radiation source for the treatment of deep-seated tumors, which was partially funded by Italian PNRR (Next Generation EU). A C-band linac prototype at lower energy, with an electron pulse of 100 nC and repetition frequency <200 Hz, is being developed to test the key choices and technology of a VHEE machine. This paper provides insights into the design strategy of the prototype, discussing the optimization of the main RF and electron beam parameters. The expected dose profiles are also shown and discussed. The progress of this innovative linac represents a step forward in the realization of a C-band compact FLASH VHEE source for cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.